Arima Genomics to Present Data at AMP Europe Showing Hi-C Sequencing Outperforms High-Coverage Whole Genome Sequencing for Lymphoma Rearrangement Detection

Arima Genomics, Inc., a cancer diagnostics company bringing DNA sequence and structure together to advance cancer therapy selection, today announced new data to be presented at the Association for ...
Labroots

Long-read Sequencing at Scale and High Accuracy

The All of Us (AoU) initiative aims to enhance personalized medical care by sequencing the genomes of over one million Americans of diverse ethnic backgrounds. To improve sequencing accuracy, we ...
technologynetworks

Peptide Mapping for Biologic Characterization: Sequence Confirmation, PTM Detection, and Lot Comparability

Peptide mapping for biologic characterization has become a cornerstone of regulatory-compliant drug development, generating the molecular fingerprint that structural review demands. Liquid ...
Morningstar

Arima Genomics to Present Data at AMP Europe Showing Hi-C Sequencing Outperforms High-Coverage Whole Genome Sequencing for Lymphoma Rearrangement Detection

Arima Genomics to Present Data at AMP Europe Showing Hi-C Sequencing Outperforms High-Coverage Whole Genome Sequencing for Lymphoma Rearrangement Detection New findings add to prior data showing Hi-C ...